Global Wilson’s Disease Treatment Market, By Treatment (Medications, others), Distribution Channel (Government, Hospitals, Medical Practitioners), and Geography - Insights, Size, Share, Opportunity Analysis, and Industry Forecast, 2022 - 2028

Global Wilson’s Disease Treatment Market, By Treatment (Medications, others), Distribution Channel (Government, Hospitals, Medical Practitioners), and Geography - Insights, Size, Share, Opportunity Analysis, and Industry Forecast, 2022 - 2028

Report Description
Wilson’s disease, also known as hepatolenticular degeneration or progressive lenticular degeneration, is a rare genetic disorder caused by copper poisoning in the body. In a healthy body, the liver filters the excess copper and releases it through urine. The liver of a person suffering from Wilson’s disease cannot perform this function. Wilson’s disease is diagnosed by blood tests where abnormalities in liver enzymes, copper levels in the blood, lower levels of ceruloplasmin, a protein that carries copper through the blood, a mutated gene or low blood sugar. Treatment include oral drug containing zinc, d-penicillamine, Tetrathiomolybdate and trientine or syprine.
Increasing awareness regarding Wilson’s disease and its symptoms is expected to fuel the market of Wilson’s disease treatment market in the near future. Moreover, growing population all over the world is expected to boost the growth of Wilson’s disease market.
Market Dynamics
Rising incidence of Wilson’s disease is due to increase in the population worldwide as Wilson’s disease is a rare genetic disorder which, is expected to favor the demand for Wilson’s disease treatment market around the globe.
According to the European Association for the study of liver (EASL) in 2011 published that Wilson’s disease is a genetic disorder that is found worldwide and is recognized to be more common than previous, with a gene frequency of 1 in 90 -150 and an incidence that is 1 in 30,000 and more than 500 distinct mutations are described in the Wilson’s gene from which 380 have a confirmed role in the pathogenesis of the disease. Whereas, European Association also stated in year 2011 that Wilson’s disease accounts for 6 - 12% of all patient with acute liver failure who are referred for emergency transplantation.
Market Taxonomy
This report segments the Wilson’s disease treatment market on basis of treatment type and the Distribution channel. On basis of treatment type, market is categorized into Medications and others. Among these medications segment dominates the Wilson’s disease treatment market throughout the forecast period. Further medication segment is sub-categorized into D-Penicillamine, Trientine, Zinc and Tetrathiomolybdate where D-penicillamine dominates the medication segment. On the basis of the distribution channel Wilson’s disease treatment market is divided into Hospitals pharmacies, Government distribution channel, retail and e-pharmacies among which hospital pharmacies dominates the market throughout the forecast period. Last segment of the market is by geography which includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Among all regions, North America contributes major market share supported by increased incidence rate of Wilson’s disease and growing inclination of the populace towards its treatment.
Key features of the study:
This report provides in-depth analysis of the Wilson’s disease treatment market and provides market size (US$ Mn) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, new product launches or approval, pipeline products, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global Wilson’s disease treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future product launch, market expansion, and marketing tactics
The global Wilson’s disease treatment market report to various stakeholders in this industry, including investors, product developers, distributors, healthcare companies, research institutes, medical device companies, new entrants, and financial analysts
Stakeholders would greatly benefit in decision making through the various strategy matrices used in analyzing the Wilson’s disease treatment market
Detailed Segmentation:
Global Wilson’s Disease Treatment Market,
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
Global Wilson’s Disease Treatment Market, By Distribution Channel:
Government
Hospitals
Medical Practitioners
Others
Global Wilson’s Disease Treatment Market, By Geography:
North America
North America Wilson’s Disease Treatment Market, By Treatment :
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
North America Wilson’s Disease Treatment Market, By Distribution Channel :
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
North America Wilson’s Disease Treatment Market, By Country:
U.S.
U.S. Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
U.S. Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Canada
Canada Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
Canada Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Europe
Europe Wilson’s Disease Treatment Market, By Treatment :
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
Europe Wilson’s Disease Treatment Market, By Distribution Channel :
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Europe Wilson’s Disease Treatment Market, By Country:
Germany
Germany Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
Germany Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
U.K.
U.K. Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
U.K. Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
France
France Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
France Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Italy
Italy Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
Italy Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Spain
Spain Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
Spain Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Russia
Russia Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
Russia Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Rest of Europe
Rest of Europe Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
Rest of Europe Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Asia Pacific
Asia Pacific Wilson’s Disease Treatment Market, By Treatment :
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
Asia Pacific Wilson’s Disease Treatment Market, By Distribution Channel:
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Asia Pacific Wilson’s Disease Treatment Market, By Country:
China
China Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
China Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
India
India Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
India Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Japan
Japan Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
Japan Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Australia
Australia Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
Australia Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
South Korea
South Korea Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
South Korea Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
ASEAN
ASEAN Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
ASEAN Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Rest of Asia Pacific
Rest of Asia Pacific Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
Rest of Asia Pacific Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Latin America
Latin America Wilson’s Disease Treatment Market, By Treatment :
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
Latin America Wilson’s Disease Treatment Market, By Distribution Channel :
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Latin America Wilson’s Disease Treatment Market, By Country:
Brazil
Brazil Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
Brazil Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Mexico
Mexico Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
Mexico Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Argentina
Argentina Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
Argentina Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Rest of Latin America
Rest of Latin America Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
Rest of Latin America Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Middle East
Middle East Wilson’s Disease Treatment Market, By Treatment :
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
Middle East Wilson’s Disease Treatment Market, By Distribution Channel :
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Middle East Wilson’s Disease Treatment Market, By Country:
GCC
GCC Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
GCC Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Israel
Israel Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
Israel Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Rest of Middle-East
Rest of Middle-East Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
Rest of Middle-East Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Africa
Africa Wilson’s Disease Treatment Market, By Treatment :
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
Africa Wilson’s Disease Treatment Market, By Distribution Channel :
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Africa Wilson’s Disease Treatment Market, By Country:
North Africa
North Africa Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
North Africa Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Central Africa
Central Africa Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
Central Africa Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
South Africa
South Africa Wilson’s Disease Treatment Market, By Treatment
Medications
D-Penicillamine
Trientine
Zinc
Tetrathiomolybdate
Others
South Africa Wilson’s Disease Treatment Market, By Distribution Channel
Hospitals Pharmacies
Government Distribution Channel
Retail and e-Pharmacies
Company Profiles
Valeant Pharmaceuticals International. Inc.*
Company Overview
Product Portfolio
Market Presence
Financial Overview
Key Developments
Strategies
Tsumura & Co
Merck & Co
VHB Life Science Inc.
Teva Pharmaceuticals USA, Inc
Wilson’s Therapeutics AB
Noble Pharma Co., Ltd
Kadmon Holding, Inc.